InvestorsHub Logo

ViaRoble

06/03/19 12:37 PM

#330538 RE: biopharm #330535

What Big Contracts for Avid? It has been over a year since they had ANY new customers. Thanks Roger and Tracy!

By the way, there is no up-side for Avid with Halo's new or expanding contracts, they all go to Cook/Catalent. Only Roche buys enzymes produced by Avid. With Catalent's expansion, they will be able to support all of the new Halo customer's demands. Avid has been and will continue to be simply a "Second Source".

Mr. Handcock, please turn this ship around before it hits the rocks!

biopharm

06/03/19 1:42 PM

#330541 RE: biopharm #330535

Now all it takes is a slight of hand connection from Ronin - John Springs Stafford to a Sumitomo affiliation etc and this little heist of an IP transfer comes to a screeching halt ...no worries, Stafford or Ronin is used to settling with SEC with no admission of guilt and will gladly pay a fine


_____

Current Assignee: Biothera Inc


DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

....the invention may also be carried out with complement activating immune suppression-relieving agents. One example may be bavituximab.

https://patents.google.com/patent/US10111901
___

April 13, 2017 published
April 19, 2017 assigned to Ronin...I mean Biothera!

July 10, 2035 and that is a long time

Inventor Nandita BoseKeith GORDENAnissa S H. ChanSteven LEONARDOJeremy GRAFFXiaohong QiuTakashi KANGASKathryn A. FRASERAdria BYKOWSKI JONASNadine OTTOSONRoss Fulton Current Assignee Biothera Inc
Worldwide applications
2015 CN WO JP EP 2016 US 2018 US
Application US15/386,887 events
2014-07-10
Priority to US201462022754P
2014-11-06
Priority to US201462076094P
2015-02-13
Priority to US201562115895P
2015-04-20
Priority to US201562149892P
2015-07-10
Priority to PCT/US2015/039977
2016-12-21
Priority to US15/386,887
2016-12-21
Application filed by Biothera Inc
2017-04-13
Publication of US20170100425A1
2017-04-19
Assigned to BIOTHERA, INC.
2018-10-30
Application granted
2018-10-30
Publication of US10111901B2
2019-06-03
Application status is Active
2035-07-10
Anticipated expiration


https://patents.google.com/patent/US10111901